MULTIPLE-SCLEROSIS - CHANGING TIMES

被引:31
|
作者
KURTZKE, JF [1 ]
机构
[1] VET AFFAIRS MED CTR,NEUROL SERV,WASHINGTON,DC 20422
关键词
MULTIPLE SCLEROSIS; DISTRIBUTION; CHANGING INCIDENCE; EPIDEMICS; TYPE-I EPIDEMIC;
D O I
10.1159/000110240
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Multiple sclerosis (MS) is distributed about the world in three zones of high, medium, and low frequency. All high- and medium-risk areas are among predominantly white populations. Migration studies indicate MS is already acquired by age 15 in high-risk endemic areas and that low-to-high migrants increase their risk from age 11 years. Therefore MS is an environmental disease ordinarily acquired in adolescence with a long incubation before symptom onset. Susceptibility is limited to the period from about age 11 to 47. In general, MS death rates have been declining over time while prevalence rates have increased. Incidence rates have also increased, however, in: northeastern Scotland; Turku, Finland; Hordaland, Norway; Rochester, Minn.; Lower Saxony; several areas of Italy. Incidence was unchanged in northernmost Norway. Conversely, incidence and prevalence rates have decreased in the Shetland-Orkneys; there was a cyclical pattern in incidence in Rostock, GDR; and there was a transient doubling of incidence in Iceland in the post-World War II decade. In the Faroe Islands, MS was absent before 1943 when a major point-source epidemic began, reaching an incidence rate of 10 per 100,000 population in 1945. This was followed by two consecutively smaller epidemics with respective peaks each about 12 years later, and there is now a new epidemic IV on these islands. Explanations for changing incidence of MS over time should bring us closer to solving the etiology of this disease.
引用
收藏
页码:1 / 8
页数:8
相关论文
共 50 条
  • [31] SENTENCE COMPREHENSION IN MULTIPLE-SCLEROSIS
    GROSSMAN, M
    ROBINSON, KM
    ONISHI, K
    THOMPSON, H
    COHEN, J
    DESPOSITO, M
    ACTA NEUROLOGICA SCANDINAVICA, 1995, 92 (04): : 324 - 331
  • [32] DIAGNOSIS AND THERAPY OF MULTIPLE-SCLEROSIS
    STEINBRECHER, A
    DICHGANS, J
    MARTIN, R
    NERVENHEILKUNDE, 1995, 14 (04) : 180 - 188
  • [33] TREATMENT OF MULTIPLE-SCLEROSIS WITH MITOXANTRONE
    MAUCH, E
    KORNHUBER, HH
    KRAPF, H
    FETZER, U
    LAUFEN, H
    EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE, 1992, 242 (2-3) : 96 - 102
  • [34] ALTITUDINAL HEMIANOPIA IN MULTIPLE-SCLEROSIS
    VIGHETTO, A
    GROCHOWICKI, M
    AIMARD, G
    NEURO-OPHTHALMOLOGY, 1991, 11 (01) : 25 - 27
  • [35] BULLOUS PEMPHIGOID AND MULTIPLE-SCLEROSIS
    TOHME, A
    MATTAR, L
    ZEBOUNI, A
    KOUSSA, S
    ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE, 1994, 121 (02): : 139 - 142
  • [36] MULTIPLE-SCLEROSIS - IS IT TRANSPLACENTALLY INDUCED
    READING, CM
    MEDICAL HYPOTHESES, 1979, 5 (11) : 1251 - 1255
  • [37] NOTES ON THE EPIDEMIOLOGY OF MULTIPLE-SCLEROSIS
    POSER, CM
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 1995, 94 (06) : 300 - 308
  • [38] DIAGNOSING MULTIPLE-SCLEROSIS IN CHILDHOOD
    VANLIESHOUT, HBM
    VANENGELEN, BGM
    SANDERS, EACM
    RENIER, WO
    ACTA NEUROLOGICA SCANDINAVICA, 1993, 88 (05): : 339 - 343
  • [39] PSYCHIATRIC ASPECTS OF MULTIPLE-SCLEROSIS
    BAL, MAA
    VAZQUEZBARQUERO, JL
    PENA, C
    MIRO, J
    BERCIANO, JA
    ACTA PSYCHIATRICA SCANDINAVICA, 1991, 83 (04) : 292 - 296
  • [40] GEOGRAPHIC SIMILARITIES BETWEEN VARICELLA AND MULTIPLE-SCLEROSIS - AN HYPOTHESIS ON THE ENVIRONMENTAL-FACTOR OF MULTIPLE-SCLEROSIS
    ROSS, RT
    CHEANG, M
    JOURNAL OF CLINICAL EPIDEMIOLOGY, 1995, 48 (06) : 731 - 737